PCR test for COVID-19 in 1.5 hours

Diagnosis and treatment of uterine and ovarian cancer (Electronic educational course)

Category of students: doctors-specialists in the areas of training: Gynecology, Oncology, Radiotherapy, Radiology, Surgery, General Medical practice, (family medicine), Therapy, Endocrinology, Pathological anatomy, "Medical business".

The complexity of the program: 36 academic hours.

Form of training: distance learning by means of an electronic educational environment with the use of interactive communication technologies.

Relevance:

For a long time, malignant neoplasms (ZNO) of the cervix consistently occupy a high 5th rank (5.2%) in the structure of cancer incidence in women.

In 2018, 17,766 cases of cervical cancer were detected, which is 22.3% more than in 2008 (13,807 cases). The "rough" incidence rate in 2018 was 22.57 per 100 thousand women. Over 10 years, this indicator has grown by 4.47 %, with an average growth rate of about 2.19 % per year. During the same period of time, the morbidity rate (an increase of 23.28%), standardized according to the world standard for the age distribution of the population, increased to the level of 15.8 per 100 thousand women, with an average annual growth rate of 2.1 %.

In comparison with other female genital ZNO (ZNO of the body of the uterus, ovary), the peak incidence of ZNO of the cervix in 2018 was determined at a younger age of 40-49 years (42.8 per 100 thousand of the corresponding population).

In 2018, 6,392 women died from cervical cancer. In the structure of causes of cancer mortality in women, cervical cancer in Russia occupies the 10th place (4.7%).

In 2018, 26,948 cases of malignant neoplasms (ZNO) of the uterine body were identified. The "rough" incidence rate in 2018 was 34.2 per 100 thousand women. Over 20 years, this indicator has grown by 87.8 %, with an average growth rate of about 3 % per year. During the same period, the morbidity rate, standardized according to the world standard for the age distribution of the population, also increased by 55.2%, its level in 2018 was 18.8 per 100 thousand population with an average annual growth rate of 2.18 %. In the age group of 65-69 years, the highest incidence rate is observed – 98.1 cases per 100 thousand women of the corresponding age. In the age groups of 50-54 and 55-59 years, ZNO of the uterine body occupies the 2nd rank in the structure of cancer incidence, 45-49, 60-64 and 65-69 years-the 3rd, 70-74 years-the 4th, in other age groups-the 6th and lower. In 2018, 6,897 women died from uterine body heat. In the structure of the causes of cancer mortality in women, the uterine body ZNO occupies the 9th place (5.0 %).

In dynamics over 10 years ,the "rough" mortality rate from uterine body heat increased by 3.01 % and amounted to 8.67 per 100 thousand women in 2018, while the standardized mortality rate for women from uterine body heat is decreasing, in 2008 it was 4.39, in 2018 – 3.98 per 100 thousand women; the decrease is 9.7 %, which indicates a true decrease in mortality from this pathology. The highest values of the mortality rate are observed in the age groups of 75 years and older – from 30.1 to 37.27 per 100 thousand women of the corresponding age.

In the structure of oncological diseases of the female population of Russia, ovarian cancer occupies the 9th place. The average age of women at the time of diagnosis is 59 years.

Age-standardized rates of ovarian cancer are about 11.03 cases per 100 thousand women. The increase in the incidence of ovarian cancer over the previous 10 years was more than 3%. In the structure of mortality from cancer in Russia among women, ovarian cancer is ranked 7th.

The above statistics make it relevant to improve the early diagnosis of these forms of cancer and lead to the development of medical technologies for drug treatment.

The purpose of the program is to improve the knowledge of specialists on the issues of modern differential diagnosis and treatment of malignant tumors of the uterus and ovaries. Informing specialists about the use of modern possibilities of chemotherapy, hormone therapy, biological therapy, radiation therapy, combined and complex methods of treatment and criteria for evaluating the effectiveness of these methods.

As part of the course, we:

  1. We will analyze the issues of epidemiology, pathogenesis and pathophysiology, morphology, diagnosis, staging, risk factors: ovarian cancer, uterine body cancer, cervical cancer, vulva and vaginal cancer.
  2. We will tell you about the features of radiation therapy and drug therapy regimens for: ovarian cancer, uterine body cancer, cervical cancer.
  3. Let's analyze the features of cytological examination of cervical scraping.
  4. Let's talk about trophoblastic disease (diagnosis and treatment).

 

Working program of the course

Sign up for the course and complete the training

GBUZ Moscow Clinical Scientific Center named after Loginov MHD Social network presence: